BackGuangzhou Wondfo Biotech ,Ltd Overview

Guangzhou Wondfo Biotech ,Ltd Receivables

Latest receivables for 300482.SZ: $750M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$747.74M
↓ 35.71% YoYΔ $-415.29M vs prior year quarter

Peer trimmed avg / median

Loading

Guangzhou Wondfo Biotech ,Ltd Receivables History

Loading

Guangzhou Wondfo Biotech ,Ltd vs. peers: Receivables Comparison

Loading

Guangzhou Wondfo Biotech ,Ltd Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Guangzhou Wondfo Biotech ,Ltd (300482.SZ) FAQ

As of the most recent data (September 2026), 300482.SZ shows a receivables of $750M. That compares with $1.2B in the prior-year period — down 35.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 300482.SZ's receivables is now $750M (was $1.2B) — a 35.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Guangzhou Wondfo Biotech ,Ltd is outperforming or lagging.

Tracking 300482.SZ's receivables over time shows whether Guangzhou Wondfo Biotech ,Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $750M That compares with $1.2B in the prior-year period — down 35.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Guangzhou Wondfo Biotech ,Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $750M) with ownership activity and broader fundamentals.

Guangzhou Wondfo Biotech ,Ltd's receivables is $750M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.